【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Pharmaceutical & Healthcare, Global, Deals Summary 9
2.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2012 9
2.1.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, 2012 by Quarter 11
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, 2012 13
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, 2012 14
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, 2012 15
2.5 Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2012 16
2.5.1 Abbott Completes Private Placement of Notes for $14.7 Billion 16
2.5.2 Nestle Completes Acquisition of Pfizer Nutrition from Pfizer for $11.85 Billion 16
2.5.3 Roche Revises Offer Price to Acquire Illumina for Up To $8.2 Billion 16
2.5.4 Aetna Receives Shareholders Approval to Acquire Coventry Health Care for $7.3 Billion 17
2.5.5 Walgreen Acquires 45% Stake in Alliance Boots from KKR And AXA Private Equity for $6.7 Billion 17
2.5.6 Watson Pharma Completes Acquisition of Actavis Group for $5.92 Billion 18
2.5.7 Bristol-Myers Squibb Completes Acquisition of Amylin Pharma for $5.3 Billion 19
2.5.8 GlaxoSmithKline Completes Public Offering of Notes for $5 Billion 19
2.5.9 UnitedHealth Completes Acquisition of 60% Stake in Amil Participacoes 19
2.5.10 WellPoint Completes Acquisition of Amerigroup for $4.9 Billion 20
3 Pharmaceuticals & Healthcare, Global, Top Deal Makers, 2012 21
4 Pharmaceuticals & Healthcare, Global, Deal Summary, by Type 22
4.1 Pharmaceuticals & Healthcare, Global, M&A, 2012 22
4.1.1 Pharmaceuticals & Healthcare, Global, M&A, 2012 by Quarter 23
4.1.2 Top M&A Deals in 2012 24
4.1.3 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2012 25
4.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2012 26
4.2.1 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2012 by Quarter 27
4.2.2 Pharmaceuticals & Healthcare, Global, IPO Deals, 2012 28
4.2.3 Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, 2012 30
4.2.4 Pharmaceuticals & Healthcare, Global, PIPE Deals, 2012 32
4.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2012 34
4.3 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, 2012 35
4.3.1 Pharmaceuticals & Healthcare, Global Debt Offerings, 2012 by Quarter 36
4.3.2 Pharmaceuticals & Healthcare, Global, Public Debt Offerings, 2012 37
4.3.3 Pharmaceuticals & Healthcare, Global, Private Debt Placements, 2012 38
4.3.4 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2012 39
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2012 40
4.4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2012 by Quarter 41
4.4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, 2012 43
4.4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Value (US$ m), 2012 44
4.4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 45
4.4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, 2012 46
4.4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), 2012 47
4.4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 48
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2012 51
4.5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2012 by Quarter 52
4.5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, 2012 53
4.5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Value (US$ m), 2012 54
4.5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 55
4.5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2012 56
4.5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2012 57
4.5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 58
4.6 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2012 61
4.6.1 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2012 by Quarter 62
4.6.2 Top Private Equity Deals in 2012 63
4.6.3 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, 2012 64
4.7 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, 2012 65
4.7.1 Pharmaceuticals & Healthcare, Global, Venture Financing Deals, 2012 by Quarter 66
4.7.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2012 67
4.7.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2012 68
4.7.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, 2012 69
4.7.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 70
4.7.6 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, 2012 71
4.7.7 Top Venture Financing Deals in 2012 72
5 Pharmaceuticals & Healthcare, Global, Deal Summary, By Market 73
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2012 73
5.1.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2012 by Quarter 75
5.1.2 Oncology – Deals of the Year 76
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2012 78
5.2.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2012 by Quarter 79
5.2.2 Central Nervous System – Deals of the Year 80
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2012 82
5.3.1 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2012 by Quarter 83
5.3.2 Infectious Disease – Deals of the Year 84
5.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2012 86
5.4.1 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2012 by Quarter 87
5.4.2 Immunology – Deals of the Year 88
5.5 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2012 90
5.5.1 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2012 by Quarter 91
5.5.2 Cardiovascular – Deals of the Year 92
5.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2012 93
5.6.1 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2012 by Quarter 94
5.6.2 Metabolic Disorders – Deals of the Year 95
5.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2012 97
5.7.1 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2012 by Quarter 98
5.7.2 Gastrointestinal – Deals of the Year 99
6 Pharmaceuticals & Healthcare, Deal Summary, By Geography 101
6.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2012 101
6.1.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2012 by Quarter 102
6.1.2 North America – Deals of the Year 103
6.2 Pharmaceuticals & Healthcare, European Region Deals, 2012 106
6.2.1 Pharmaceuticals & Healthcare, Europe, Deals, 2012 by Quarter 107
6.2.2 Europe – Deals of the Year 108
6.3 Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, 2012 110
6.3.1 Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, 2012 by Quarter 111
6.3.2 Asia-Pacific – Deals of the Year 112
6.4 Pharmaceuticals & Healthcare, Rest of the World (ROW) Deals, 2012 114
6.4.1 Pharmaceuticals & Healthcare, Rest of the World Deals, 2012 by Quarter 115
6.4.2 Rest of the World – Deals of the Year 116
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 117
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2012 117
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2012 118
8 Further Information 119
8.1 Methodology 119
8.2 About GlobalData 120
8.3 Contact Us 120
8.4 Disclosure information 120
8.5 Disclaimer 120
【レポート販売概要】
■ タイトル：Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends – 2012■ 英文：Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012
■ 発行日：2013年3月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160699
■ 調査対象地域：グローバル
- 断熱材の世界市場2017-2021：ウール製断熱材、発泡プラスチック製断熱材About Insulation Building insulation regulates the heat generated inside a building. Insulation materials help in controlling the heat that is dissipated through conduction, convection, and radiation. Besides thermal properties, insulation materials also ensure protection against sound, fire, and impact. Oversupply of oil and gas coupled with low demand has resulted in low prices worldwide, leadin …
- Mobile Commerce 360Mobile commerce is exploding with applications and services driven by emerging technologies, use cases, and business models. M-commerce is quite different from traditional e-commerce as the ecosystem and value chain are more dynamic and are evolving in a different manner than e-commerce as a whole. Mobile Commerce 360 is an annual subscription service that provides research, analysis, and advisory …
- 遠隔医療（テレヘルス）ソリューションの世界市場About Telehealth Telehealth is a medium of communication between patients and doctors. Telehealth enables doctors to stay in touch with their patients, monitor their health, and provide consultation if need arises. It includes the use of telecommunication technology in providing medical services to patients especially in remote areas. It is very helpful for the patients who earlier had to travel m …
- 世界のグラファイト（黒鉛）市場動向（2012-2016）TechNavio's analysts forecast the Global Graphite market to grow at a CAGR of 5.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing use of graphite in batteries. The Global Graphite market has also been witnessing an increasing production of synthetic graphite. However, the increasing demand-supply gap could pose a challenge to the grow …
- 飼料用植物性添加剤の世界市場：精油、ハーブ・香辛料、含油樹脂The global feed phytogenics market size is projected to reach USD 769.5 Million by 2021, at a CAGR of around 7.1% from 2016 to 2021. The global market has grown exponentially in the last few years. European countries such as Germany, France, and Russia are the primary targets of the industry. Ban of in-feed antibiotics by the European Union and rise in awareness about animal health & feed quality …
- セメントの世界市場動向2014/2015The report presents a thorough study of cement, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing cement worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: cement production in the country, major manufacturers …
- 世界のシアン化金カリウム市場2015The Global Gold Potassium Cyanide Industry Report 2015 is a professional and in-depth study on the current state of the Gold Potassium Cyanide industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Gold Potassium Cyanide market analysis is provided for the international markets including development tren …
- ブタンジオール(BDO)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world butanediol market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insigh …
- ブラジルの気道装置・麻酔装置市場Brazil Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "Brazil Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the Brazil Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, Anesthesia Masks, …
- 日本の心臓血管外科用機器市場見通し（～2021）Japan Cardiovascular Surgery Outlook to 2021 Summary GlobalData’s new report, "Japan Cardiovascular Surgery Outlook to 2021", provides key procedures data on the Japan Cardiovascular Surgery. The report provides procedure volumes within market segments - Coronary Artery Bypass Graft (CABG) Procedures and Isolated Valve Procedures. The data in the report is derived from dynamic market forecast mode …
- テレビ広告支出の世界市場2015-2019About TV Ad Spending TV advertising enables advertisers to create awareness about their products and influence the buying decision of consumers. Since TV is the most widely viewed medium worldwide, advertisers are drawn to this medium of advertising. Advertising on TV can be done using traditional commercial channels or multichannel campaigns. Advertisers have increased their spending on TV advert …
- グローバルにおけるSaas基盤ERP市場（2014-2018） About SaaS-based ERP SaaS-based ERP software refers to the deployment of ERP applications as a web-based subscription service. SaaS-based ERP software is operated by a third-party organization as opposed to the installation and maintenance of an On-premise business system. In the pay-per-use model, ERP software is hosted by a third party from a remote location, and the outsourcing company pays acc …
- データファブリックの世界市場：展開別（オンプレミス、クラウド）、種類別（ディスクベースデータファブリック、インメモリデータファブリック）、企業規模別（中小企業、大企業）、業種別（BFSI、テレコミュニケーション＆IT、小売、ヘルスケア、製造、政府、エネルギー＆公益事業、メディア＆エンターテイメント、その他）Data fabric operates as a single and consistent data management framework that can access data from any location, anytime by streamlining and integrating data management processes across all access points and sources of data. In addition, the platform developed for data fabric operations are consolidated frameworks that manage, transfer, and secure data across multiple remote and incompatible data …
- Market?Opportunity: M2M in HealthcareMachine-to-machine (M2M) communication is a revolutionary technology that allows effective supervision and maintenance of physical assets by networking. It helps the companies in many ways: decrease costs, increase income and makes it possible to provide a superior customer service. ? M2M communication over IP Next-Generation Networks (IP NGNs) in combination with cloud-based services represents n …
- データセンター用サーバの世界市場：タワーサーバ、ラックサーバ、ブレードサーバ、マイクロサーバAbout data center servers Servers are the backbone of a data center operation, and they are used mainly for the transfer of data from a data center to its associated computers. A server operation is dependent on hardware reliability and durability. A typical server comprises of dual-power supplies, RAID disk system, ECC memory, which are tested for operations by vendors. Mission-critical servers a …
